Related Experiment Video
Updated: Feb 4, 2026

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma
Published on: January 25, 2015
Hepatitis E Virus Papain-Like Cysteine Protease Inhibits Type I Interferon Induction by Down-Regulating Melanoma
1Korea Zoonosis Research Institute & Genetic Engineering Research Institute, Chonbuk National University, Iksan 54531, Republic of Korea.
Abstract:
Upon viral infection, the host cell recognizes the invasion through a number of pattern recognition receptors. Melanoma differentiation associated gene 5 (MDA5) and retinoic acid-inducible gene-I (RIG-I) recognize RNA molecules derived from invading viruses, activating down-stream signaling cascades, culminating in the induction of the type I interferon. On the other hand, viruses have evolved to evade type I interferon-mediated inhibition. Hepatitis E virus has been shown to encode a few antagonists of type I interferon and it is not surprising that viruses encode multiple mechanisms of viral evasion. In the present study, we demonstrated that HEV PCP strongly down-regulates MDA5-mediated activation of interferon β induction in a dose-dependent manner. Interestingly, MDA5 protein expression was almost completely abolished. In addition, polyinosinic polycytidylic acid (poly(I:C))- and Sendai virus-mediated activation of type I interferon responses were similarly abrogated in the presence of HEV PCP. Furthermore, HEV PCP down-regulates several molecules that play critical roles in the induction of type I IFN expression. Taken together, these data collectively suggest that HEV-encoded PCP is a strong antagonist of type I interferon.
Insights
Hepatitis E virus protein (HEV PCP) inhibits the host
Area of Science:
- Immunology
- Virology
- Molecular Biology
Background:
- Host cells detect viral RNA using pattern recognition receptors like MDA5 and RIG-I.
- Activation of these receptors triggers signaling cascades, leading to Type I Interferon (IFN) production.
- Viruses possess mechanisms to counteract host antiviral responses, including Type I IFN.
Purpose of the Study:
- To investigate the role of Hepatitis E virus (HEV) protein, specifically HEV PCP, in modulating Type I IFN induction.
- To determine if HEV PCP acts as an antagonist to the MDA5-mediated antiviral pathway.
Main Methods:
- Dose-dependent analysis of HEV PCP's effect on interferon-beta induction.
- Assessment of MDA5 protein expression levels in the presence of HEV PCP.
- Evaluation of HEV PCP's impact on Type I IFN responses triggered by poly(I:C) and Sendai virus.
Main Results:
- HEV PCP significantly down-regulates MDA5-mediated interferon-beta induction in a dose-dependent manner.
- MDA5 protein expression was substantially reduced by HEV PCP.
- HEV PCP abrogated Type I IFN responses induced by poly(I:C) and Sendai virus, and down-regulated key molecules in IFN induction.
Conclusions:
- HEV-encoded Protein (HEV PCP) functions as a potent antagonist of Type I Interferon.
- HEV PCP interferes with host antiviral defenses by inhibiting MDA5-mediated signaling pathways.
Related Concept Videos
Regulation of Expression Occurs at Multiple Steps
Transcription results in the generation of precursor (pre-mRNA) that consists of both exons and introns, which needs further processing before being translated to a...
Master Transcription Regulators
Gene Regulation During Sporulation
Epigenetic Regulation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Circadian Rhythms and Gene Regulation

